MESENCHYMAL CELL DIFFERENTIATION
间充质细胞分化
基本信息
- 批准号:3897533
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:adipocytes bioassay biological response modifiers cell differentiation cell growth regulation deficient growth media epidermal growth factor gene expression high performance liquid chromatography hormone regulation /control mechanism insulin laboratory rat mesenchyme messenger RNA molecular sieving muscle cells neoplastic cell culture for noncancer research tissue /cell culture transforming growth factors
项目摘要
The processes of proliferation, commitment and differentiation of
mesenchymal cells will be studied at the cellular level using the
teratoma-derived, bipotential cell line 1246 and an insulin-
independent variant cell line derived from 1246 cells as a model
system. The 1246 cell line has the following properties; (1) it can
differantiate either into adipocytes or into muscle cells; (2) it can
proliferate and undergo adipose differentiation in defined medium
whereas other adipogenic cell lines can grow in defined medium
but require fetal calf serum to differentiate; 3) its growth and
differentiation are stringently dependent on the presence of
insulin; and 4) its conditioned medium is able to replace serum to
stimulate the differentiation of several adipogenic cell lines.
From 1246 cells, an insulin-independent variant cell line has been
isolated. This cell line which has lost the ability to differentiate
produces in its culture medium an adipose differentiation inhibitor
active to block differentiation of several adipogenic cell lines and
of primary cultures of rat and mouse adipocytes. Experiments are
proposed to characterize, purify and study the expression of both
types of adipose differentiation regulators produced by both cell
lines. This study will be part of the long-term objective of our
investigations related to the characterization of factors
controlling growth, commitment and differentiation processes of
mesenchymal-derived cell lines and to understand their
mechanism of action.
细胞的增殖、定型和分化过程
间充质细胞将在细胞水平上使用
畸胎瘤衍生的双能细胞系1246和胰岛素-
来源于1246细胞的独立变异细胞系作为模型
系统 1246细胞系具有以下性质:(1)它可以
分化成脂肪细胞或肌肉细胞;(2)它可以
在成分确定的培养基中增殖并经历脂肪分化
而其它成脂细胞系可以在成分确定的培养基中生长
但需要胎牛血清来分化; 3)其生长,
分化严格依赖于
胰岛素;和4)其条件培养基能够代替血清,
刺激几种成脂细胞系的分化。
从1246个细胞中,已经获得了胰岛素非依赖性变异细胞系。
与世隔绝 这种失去分化能力的细胞系
在其培养基中产生脂肪分化抑制剂
具有阻断几种成脂细胞系分化的活性,
大鼠和小鼠脂肪细胞的原代培养物。 实验
提出了表征,纯化和研究两者的表达
两种细胞产生的脂肪分化调节因子的类型
线 这项研究将是我们长期目标的一部分,
与因素特性有关的调查
控制增长,承诺和分化过程
间充质来源的细胞系,并了解其
作用机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GINETTE SERRERO其他文献
GINETTE SERRERO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GINETTE SERRERO', 18)}}的其他基金
DEVELOPMENT OF NOVEL ANTICANCER AGENT TO POTENTIATE SENSITIVITY TO ANTI-ESTROGEN THERAPY
开发新型抗癌剂以增强抗雌激素治疗的敏感性
- 批准号:
8935272 - 财政年份:2014
- 资助金额:
-- - 项目类别:
FACTORS PRODUCED BY TERATOMA VARIANTS AND IN VIVO TUMORIGENICITY
畸胎瘤变异体产生的因子和体内致瘤性
- 批准号:
3794982 - 财政年份:
- 资助金额:
-- - 项目类别:
HORMONAL CONTROL AND GENE EXPRESSION OF SDIPOSE DIFFERENTIATION
激素控制和 SDIPOSE 分化的基因表达
- 批准号:
3892946 - 财政年份:
- 资助金额:
-- - 项目类别:
FACTORS PRODUCED BY TERATOMA VARIANTS AND IN VIVO TUMORIGENICITY
畸胎瘤变异体产生的因子和体内致瘤性
- 批准号:
3812541 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
- 批准号:41606166
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of advanced bioassay analysis system for internal dose assessment
开发用于内部剂量评估的先进生物测定分析系统
- 批准号:
23H03142 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
This service is for The BPN Biologics program requires bioassay development expertise in order to support active cooperative agreements for drug development and discovery.
该服务适用于 BPN Biologics 计划需要生物测定开发专业知识,以支持药物开发和发现的积极合作协议。
- 批准号:
10949343 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development of a three-dimensional microkidney model and its disease model for bioassay
用于生物测定的三维微肾脏模型及其疾病模型的开发
- 批准号:
23H01983 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a qualified pharmacokinetic bioassay to support preclinical and clinical studies of MM-008, a non-hormonal contraceptive antibody
开发合格的药代动力学生物测定法以支持非激素避孕抗体 MM-008 的临床前和临床研究
- 批准号:
10459074 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Development of rapid and sensitive bioassay methods to contribute to actinide internal exposure medical response
开发快速、灵敏的生物测定方法,有助于锕系元素内照射医疗反应
- 批准号:
22K12384 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of simple bioassay for detection of environmental trace contaminants and demonstration in Asian countries
开发用于检测环境痕量污染物的简单生物测定法并在亚洲国家进行示范
- 批准号:
21H01577 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
L2M Market Assessment Grant: a bioassay to predict birth timing.
L2M 市场评估补助金:预测出生时间的生物测定。
- 批准号:
571251-2022 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Idea to Innovation